enquires@avipep.com.au

Avipep Pty Ltd is a biotechnology company specializing in commercialization of a new platform technology for the development of proteins related to the binding domains of antibodies, which have tremendous potential for the detection and treatment of cancer and major human diseases.

This technology platform provides a method of producing, improving and stabilizing these expressed antibody-like proteins or "Avibodies". Avipep’s technology can customize avibodies for immunotargeting, imaging and/or therapy.

Avipep's website is currently under construction. Please watch this space for future changes.